More heads to roll at Cyberonics
This article was originally published in Clinica
Executive Summary
Beleaguered neuromodulation therapy specialist Cyberonics is to slash its already-reduced workforce by a further 12%, a fallout of the firm's failure to gain reimbursement coverage for its anti-depression therapy.